Clinical Drug Experience Knowledgebase

23-valent pneumococcal polysaccharide vaccine (pneumovax-23) (6 trials)

acellular pertussis vaccine (including diptheria and tetanus toxoids) (Tripedia) (7 trials)

bivalent oral polio vaccine (bopv), type 1 and type 3 (BOPV) (3 trials)

covax-19 (6 trials)

covid-19 vaccine (vero cells) (4 trials)

diphtheria toxoid (2 trials)

ev71 vaccine (2 trials)

hepatitis a (live) vaccine (1 trial)

hepatitis a vaccine, inactivated (vaqta) (2 trials)

inactivated covid-19 vaccine (10 trials)

inactivated influenza vaccine (11 trials)

Inactivated polio virus - Enhanced (IPOL) (4 trials)

inactivated rabies vaccine (Imovax) (1 trial)

inactivated sabin strain polio virus (2 trials)

inactivated SARS-Cov-2 vaccine (3 trials)

inactivated varicella vaccine (1 trial)

live attenuated chimeric japanese encephalitis vaccine (1 trial)

live attenuated varicella vaccine (Varivax) (8 trials)

live oral poliovirus type 1, 2 and 3 (Trivalent oral polio vaccine - Sabin) (3 trials)

measles, mumps, and rubella vaccine (MMR) (5 trials)

measles-rubella vaccine (M-R-Vax) (1 trial)

multi-valent pneumococcal conjugate vaccine (1 trial)

split virion influenza vaccine (2 trials)

tetanus toxoid (2 trials)

tivantinib (1 trial)

bbibp-corv (1 trial)

bevacizumab (avastin) (2 trials)

bibp omicron inactivated covid-19 vaccine (vero cell) (1 trial)

bivalent gii.4/gi.1 (1 trial)

carboplatin (paraplatin) (2 trials)

Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine (Kinrix) (1 trial)

docetaxel (taxotere) (1 trial)

haemophilus influenzae type b conjugate vaccine (HibTITER) (1 trial)

libp-rec (1 trial)

omicron covid-19 vaccine (vero cell), inactivated (3 trials)

paclitaxel (taxol) (1 trial)

recombinant sars-cov-2 vaccine (2 trials)

rimabotulinumtoxinB (Myobloc) (3 trials)

rituximab (rituxan) (1 trial)

trastuzumab (herceptin) (1 trial)

aluminum hydroxide (Gaviscon) (3 trials)

covid 19 immune globulin (1 trial)

cytokine induced killer cells (1 trial)

gamma-delta t cells (1 trial)

gi.1/gii.4 bivalent vlp vaccine (2 trials)

interferon alpha-1 (2 trials)

nvsi-06-08 (1 trial)

phosphate (1 trial)

plague vaccine (1 trial)

valaciclovir (Valtrex) (1 trial)

zsvg-02 (2 trials)

acyw135 mcv (1 trial)

anti-cd19-car gamma-delta t cells (1 trial)

Anti-CD52 Monoclonal Antibody (1 trial)

autologous humanized anti-cd19 and anti-cd20 dual specific car-t cells (1 trial)

cd19 car-t cells (1 trial)

dexamethasone (1 trial)

diphenhydramine (benadryl) (1 trial)

methylprednisolone (medrol) (1 trial)

muc1-gene-dc-ctl (1 trial)

muc1-peptide-dc-ctl (1 trial)

pegloticase (krystexxa) (1 trial)

sibp-03 (1 trial)